The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 1-p-tolyl-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate ID: ALA595090
PubChem CID: 46227678
Max Phase: Preclinical
Molecular Formula: C20H20N2O2
Molecular Weight: 320.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)N1CCc2c([nH]c3ccccc23)C1c1ccc(C)cc1
Standard InChI: InChI=1S/C20H20N2O2/c1-13-7-9-14(10-8-13)19-18-16(11-12-22(19)20(23)24-2)15-5-3-4-6-17(15)21-18/h3-10,19,21H,11-12H2,1-2H3
Standard InChI Key: NQXVXCJCVOJVAB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
11.1453 -3.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1442 -4.1818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8569 -4.5935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8551 -2.9453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5684 -3.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5686 -4.1818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3568 -4.4377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3564 -3.0970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8438 -3.7685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6645 -3.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0045 -2.9258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5169 -2.2547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6897 -2.3396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1465 -4.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7498 -5.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1754 -5.7704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9987 -5.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3945 -5.0274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4259 -6.4563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8258 -2.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2701 -3.5802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2032 -2.1569 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9687 -4.2591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0918 -3.5416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
3 6 2 0
10 14 1 0
6 7 1 0
14 15 2 0
7 9 1 0
15 16 1 0
8 5 1 0
16 17 2 0
8 9 2 0
17 18 1 0
18 23 2 0
23 14 1 0
1 2 2 0
17 19 1 0
5 4 2 0
11 20 1 0
4 1 1 0
20 21 1 0
5 6 1 0
20 22 2 0
2 3 1 0
21 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 320.39Molecular Weight (Monoisotopic): 320.1525AlogP: 4.19#Rotatable Bonds: 1Polar Surface Area: 45.33Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.12CX LogD: 4.12Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.45
References 1. Miller JF, Turner EM, Sherrill RG, Gudmundsson K, Spaltenstein A, Sethna P, Brown KW, Harvey R, Romines KR, Golden P.. (2010) Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infection., 20 (1): [PMID:19914830 ] [10.1016/j.bmcl.2009.10.123 ]